Gene Expression Changes of Brain Tissue in Human Temporal Lobe Epilepsy With Hippocampal Sclerosis

NCT04917939 — Active not recruiting, 10 participants, Second Affiliated Hospital, Zhejiang University, School of Medicine

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT04917939
StatusActive not recruiting
Study typeObservational
Enrollment10 (Estimated)
SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine (Other)
ConditionsEpilepsy, Hippocampal Sclerosis
InterventionsRNA sequencing (Other)
Datesstart 2021-04-19, primary completion 2026-12-31 (estimated), completion 2026-12-31 (estimated), first posted 2021-06-08, last updated 2026-04-27
Locations1 site in China

Related Papers Related Patents Related Grants Related Experts
All trials for Epilepsy All trials for Hippocampal Sclerosis All trials of RNA sequencing

-Summary

Epilepsy is a common neurological disease, manifested in the sudden abnormal discharge of neurons leading to short-term brain dysfunction, has become the neurology after headache the second most common disease. In China, the prevalence of epilepsy is about 4.7-8.5 per 1,000, and more than 400,000 new cases of epilepsy are developed each year. Of these, 30% of patients were treated with ineffective medication, developing into a drug-incurable epilepsy that required surgery and other treatments. The most common type of epilepsy is temporal lobe epilepsy, while the common complication in temporal lobe epilepsy is hippocampal sclerosis, which often requires surgical removal. The incidence of inner temporal lobe epilepsy associated with hippocampal sclerosis is increasing, but its exact cause and specific pathogenesis are still unclear, so clarifying its pathogenesis will contribute to the understanding of temporal lobe epilepsy and the improvement of surgical procedures. This study is intended to get single-cell transcriptome as well as spatial transcriptome data of temporal lobe and hippocampus samples. By studying gene expression change associated with epilepsy and hippocampus sclerosis, we intended to find possible prognostic-related molecules and to deepen understanding of pathological changes in epilepsy at the molecular level.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
epilepsy with HSOther: RNA sequencing
epilepsy without HSOther: RNA sequencing
  • RNA sequencing (Other): Samples in both groups will be sequenced by single-cell sequencing and spatial transcription sequencing.

+Outcome measures

Primary outcomes

  • RNA sequencing data [up to 24 weeks]: Single-cell sequencing and spatial transcription sequencing data of samples.

+Eligibility

Sex: All

Inclusion Criteria:

* Patients confirmed in our hospital as having temporal lobe epilepsy and intending surgery to remove temporal lobe and hippocampal tissue;
* Volunteer to participate in this clinical trial, comply with the requirements of this clinical trial and sign an informed consent form.

Exclusion Criteria:

* Chronic diseases of the central nervous system other than temporal lobe epilepsy;
* Other patients that are not suitable for this clinical trial determined by the researchers;

+Locations (1)

FacilityCityCountryStatus
2ndAffiliated Hospital, School of Medicine, Zhejiang University, ChinaHangzhou, ZhejiangChina

+Investigators

  • 2nd Affiliated Hospital, Study chair, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China